125 related articles for article (PubMed ID: 23461830)
1. Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial.
Ross JE; Scangarella-Oman N; Jones RN
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):437-9. PubMed ID: 23461830
[TBL] [Abstract][Full Text] [Related]
2. Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.
Miller AA; Traczewski MM; Huband MD; Bradford PA; Mueller JP
J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315953
[TBL] [Abstract][Full Text] [Related]
3. Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
Odland BA; Erwin ME; Jones RN
J Clin Microbiol; 2000 Jan; 38(1):453-5. PubMed ID: 10618141
[TBL] [Abstract][Full Text] [Related]
4. Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone.
Ross JE; Liverman LC; Jones RN
J Clin Microbiol; 2011 Aug; 49(8):3009-11. PubMed ID: 21653768
[TBL] [Abstract][Full Text] [Related]
5. Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitor.
Anderegg TR; Jones RN;
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):55-7. PubMed ID: 14761722
[TBL] [Abstract][Full Text] [Related]
6. Determination of disk diffusion and MIC quality control guidelines for GSK2140944, a novel bacterial type II topoisomerase inhibitor antimicrobial agent.
Ross JE; Scangarella-Oman NE; Flamm RK; Jones RN
J Clin Microbiol; 2014 Jul; 52(7):2629-32. PubMed ID: 24759716
[TBL] [Abstract][Full Text] [Related]
7. Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam.
Belley A; Huband MD; Fedler KA; Watters AA; Flamm RK; Shapiro S; Knechtle P
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167844
[TBL] [Abstract][Full Text] [Related]
8. Determination of Disk Diffusion and MIC Quality Control Guidelines for Solithromycin, a Novel Fluoroketolide Antibacterial, against Neisseria gonorrhoeae.
Riedel S; Ross JE; Farrell DJ; Flamm RK; Jones RN
J Clin Microbiol; 2015 Dec; 53(12):3888-90. PubMed ID: 26378286
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of diffusion and dilution methods to determine the antibacterial activity of plant extracts.
Klancnik A; Piskernik S; Jersek B; Mozina SS
J Microbiol Methods; 2010 May; 81(2):121-6. PubMed ID: 20171250
[TBL] [Abstract][Full Text] [Related]
10. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
Gales AC; Reis AO; Jones RN
J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.
Brown SD; Traczewski MM
J Clin Microbiol; 2007 Jul; 45(7):2173-9. PubMed ID: 17494717
[TBL] [Abstract][Full Text] [Related]
12. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
Hackel MA; Karlowsky JA; Dressel D; Sahm DF
J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
[TBL] [Abstract][Full Text] [Related]
13. Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.
Ross JE; Scangarella-Oman NE; Miller LA; Sader HS; Jones RN
J Clin Microbiol; 2011 Nov; 49(11):3928-30. PubMed ID: 21918031
[TBL] [Abstract][Full Text] [Related]
14. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
Jones RN; Anderegg TR; Swenson JM;
J Clin Microbiol; 2005 Feb; 43(2):925-7. PubMed ID: 15695708
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Quality Control Study Group.
Jones RN; Marshall SA; Erwin ME
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):103-10. PubMed ID: 10354859
[TBL] [Abstract][Full Text] [Related]
16. Validation and reproducibility assessment of tigecycline MIC determinations by Etest.
Bolmström A; Karlsson A; Engelhardt A; Ho P; Petersen PJ; Bradford PA; Jones CH
J Clin Microbiol; 2007 Aug; 45(8):2474-9. PubMed ID: 17522277
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
Walkty A; Adam HJ; Laverdière M; Karlowsky JA; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):348-55. PubMed ID: 21353964
[TBL] [Abstract][Full Text] [Related]
18. Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole.
McDermott PF; Barry AL; Jones RN; Stein GE; Thornsberry C; Wu CC; Walker RD
J Clin Microbiol; 2001 Dec; 39(12):4283-7. PubMed ID: 11724833
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of susceptibility testing methods for polymyxin.
Behera B; Mathur P; Das A; Kapil A; Gupta B; Bhoi S; Farooque K; Sharma V; Misra MC
Int J Infect Dis; 2010 Jul; 14(7):e596-601. PubMed ID: 20045367
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of the essential oil from Ferula gummosa seed.
Eftekhar F; Yousefzadi M; Borhani K
Fitoterapia; 2004 Dec; 75(7-8):758-9. PubMed ID: 15567258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
